A focus on the association of Apol1 with kidney disease in children

被引：12
|
作者：
Ekulu, Pepe M. [1 ,2 ]
Nkoy, Agathe B. [2 ]
Adebayo, Oyindamola C. [1 ]
Kazadi, Orly K. [2 ]
Aloni, Michel N. [2 ]
Arcolino, Fanny O. [1 ]
Ngiyulu, Rene M. [2 ]
Gini, Jean-Lambert E. [2 ]
Lepira, Francois B. [3 ]
van den Heuvel, Lamberthus P. [1 ,4 ]
Levtchenko, Elena N. [5 ,6 ]
机构：
[1] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium
[2] Univ Kinshasa, Div Nephrol, Dept Pediat, Fac Med,Univ Hosp Kinshasa, Kinshasa, DEM REP CONGO
[3] Univ Kinshasa, Div Nephrol, Dept Internal Med, Fac Med,Univ Hosp Kinshasa, Kinshasa, DEM REP CONGO
[4] Radboud Univ Nijmegen, Dept Pediat Nephrol, Med Ctr, Nijmegen, Netherlands
[5] Katholieke Univ Leuven, Dept Pediat Nephrol, Univ Hosp Leuven, Leuven, Belgium
[6] Katholieke Univ Leuven, Dept Dev & Regenerat, Univ Hosp Leuven, Leuven, Belgium
来源：
PEDIATRIC NEPHROLOGY | 2021年 / 36卷 / 04期
关键词：
APOL1; Chronic kidney disease; Children; Genetics; Sickle cell disease; HIV-associated nephropathy; STAGE RENAL-DISEASE; AFRICAN-AMERICAN CHILDREN; RISK VARIANTS; APOLIPOPROTEIN L1; NEPHROPATHY; GENE; GENOTYPE; OUTCOMES; ALLELES; ADULTS;
D O I：
10.1007/s00467-020-04553-z
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Individuals of African origin have an increased risk of developing various progressive chronic kidney diseases (CKD). This risk has been attributed to genetic variants (G1, G2) in apolipoprotein-L1 (APOL1) gene. In the pediatric population, especially in children affected by sickle cell disease (SCD), by human immunodeficiency virus (HIV), or with various glomerular diseases, APOL1 risk variants have been associated with the development of hypertension, albuminuria, and more rapid decline of kidney function. The present review focuses on existing APOL1-related epidemiological data in children with CKD. It also includes data from studies addressing racial disparities in CKD, the APOL1-related innate immunity, and the relationship between APOL1 and CKD and pathogenic pathways mediating APOL1-related kidney injury.
引用
收藏
页码：777 / 788
页数：12
相关论文
共 50 条
  • [21] Association of Recipient APOL1 Kidney Risk Alleles With Kidney Transplant Outcomes
    Roy, Neil
    Morales-Alvarez, M. Catalina
    Anis, Karim H.
    Goral, Simin
    Doria, Cataldo
    Kopp, Jeffrey B.
    Winkler, Cheryl A.
    Feng, Rui
    Rosas, Sylvia E.
    TRANSPLANTATION, 2023, 107 (12) : 2575 - 2580
  • [22] APOL1: The Balance Imposed by Infection, Selection, and Kidney Disease
    Beckerman, Pazit
    Susztak, Katalin
    TRENDS IN MOLECULAR MEDICINE, 2018, 24 (08) : 682 - 695
  • [23] APOL1 Kidney Disease Risk Variants: An Evolving Landscape
    Dummer, Patrick D.
    Limou, Sophie
    Rosenberg, Avi Z.
    Heymann, Jurgen
    Nelson, George
    Winkler, Cheryl A.
    Kopp, Jeffrey B.
    SEMINARS IN NEPHROLOGY, 2015, 35 (03) : 222 - 236
  • [24] Apolipoprotein-L1 (APOL1): From Sleeping Sickness to Kidney Disease
    Pays, Etienne
    CELLS, 2024, 13 (20)
  • [25] Ten years in: APOL1 reaches beyond the kidney
    Waitzman, Joshua S.
    Lin, Jennie
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2019, 28 (04) : 375 - 382
  • [26] APOL1 Renal Risk Variants Are Associated With Chronic Kidney Disease in Children and Youth With Perinatal HIV Infection
    Purswani, Murli U.
    Patel, Kunjal
    Winkler, Cheryl A.
    Spector, Stephen A.
    Hazra, Rohan
    Seage, George R., III
    Mofenson, Lynne
    Karalius, Brad
    Scott, Gwendolyn B.
    Van Dyke, Russell B.
    Kopp, Jeffrey B.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 73 (01) : 63 - 68
  • [27] Genetic Variants of APOL1 Are Major Determinants of Kidney Failure in People of African Ancestry With HIV
    Hung, Rachel K. Y.
    Binns-Roemer, Elizabeth
    Booth, John W.
    Hilton, Rachel
    Harber, Mark
    Santana-Suarez, Beatriz
    Campbell, Lucy
    Fox, Julie
    Ustianowski, Andrew
    Cosgrove, Catherine
    Burns, James E.
    Clarke, Amanda
    Price, David A.
    Chadwick, David
    Onyango, Denis
    Hamzah, Lisa
    Bramham, Kate
    Sabin, Caroline A.
    Winkler, Cheryl A.
    Post, Frank A.
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (04): : 786 - 796
  • [28] The Expanding Role of APOL1 Risk in Chronic Kidney Disease and Cardiovascular Disease
    Estrella, Michelle M.
    Parekh, Rulan S.
    SEMINARS IN NEPHROLOGY, 2017, 37 (06) : 520 - 529
  • [29] APOL1 Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans
    Gbadegesin, R. A.
    Ulasi, I
    Ajayi, S.
    Raji, Y.
    Olanrewaju, T.
    Osafo, C.
    Ademola, A. D.
    Asinobi, A.
    Winkler, C. A.
    Burke, D.
    Arogundade, F.
    Ekem, I
    Plange-Rhule, J.
    Mamven, M.
    Matekole, M.
    Amodu, O.
    Cooper, R.
    Antwi, S.
    Adeyemo, A. A.
    Ilori, T. O.
    Adabayeri, V
    Nyarko, A.
    Ghansah, A.
    Amira, T.
    Solarin, A.
    Awobusuyi, O.
    Kimmel, P. L.
    Brosius, F. C.
    Makusidi, M.
    Odenigbo, U.
    Kretzler, M.
    Hodgin, J. B.
    Pollak, M. R.
    Boima, V
    Freedman, B. I.
    Palmer, N. D.
    Collins, B.
    Phadnis, M.
    Smith, J.
    Agwai, C. I.
    Okoye, O.
    Abdu, A.
    Wilson, J.
    Williams, W.
    Salako, B. L.
    Parekh, R. S.
    Tayo, B.
    Adu, D.
    Ojo, A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024,
  • [30] Population genetics of chronic kidney disease: The evolving story of APOL1
    Wasser, Walter G.
    Tzur, Shay
    Wolday, Dawit
    Adu, Dwomoa
    Baumstein, Donald
    Rosset, Saharon
    Skorecki, Karl
    JOURNAL OF NEPHROLOGY, 2012, 25 (05) : 603 - 618
12345